N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS
- PMID: 16410181
- DOI: 10.1016/j.mri.2005.10.021
N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS
Abstract
We investigated the absolute concentration of N-acetylaspartate (NAA) in the thalami of neuropathic pain patients and healthy comparison subjects by single-voxel proton magnetic resonance spectroscopy ((1)H-MRS). (1)H-MRS was performed with a 1.5-T MR system on a voxel in the thalamus bilaterally in 9 neuropathic pain patients and 14 healthy control subjects. We measured the absolute concentration of NAA using a linear combination model. The NAA concentration in the thalamus decreased significantly on the contralateral side in seven patients and on the ipsilateral side in two patients, as compared with the mean NAA concentration of the healthy control subjects. The NAA concentrations in two patients who did not respond to standard pain treatments were extremely decreased. Our results using (1)H-MRS suggest that neuropathic pain seems to be associated with an abnormal balance of the neural activity in the thalamus. The NAA concentration of the thalamus may be related to the efficacy of therapy. (1)H-MRS may serve as a useful noninvasive tool for evaluating thalamic neural activity in neuropathic pain patients.
Similar articles
-
[H magnetic resonance spectroscopy investigation of the anterior cingulate cortex and prefrontal cortex in chronic pain patients].Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Feb;28(1):23-8. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008. PMID: 18411706 Japanese.
-
Metabolite concentration ratios in thalami of patients with migraine and trigeminal neuralgia measured with 1H-MRS.Neurol Res. 2008 Apr;30(3):229-33. doi: 10.1179/016164107X235473. Epub 2007 Sep 10. Neurol Res. 2008. PMID: 17848209
-
Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.Psychiatry Clin Neurosci. 2006 Jun;60(3):365-72. doi: 10.1111/j.1440-1819.2006.01515.x. Psychiatry Clin Neurosci. 2006. PMID: 16732755
-
ALS surrogate markers. MRS.Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:111-4. doi: 10.1080/17434470410019861. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512889 Review.
-
N-acetylaspartate: a literature review of animal research on brain ischaemia.J Neurochem. 2004 Aug;90(4):776-83. doi: 10.1111/j.1471-4159.2004.02583.x. J Neurochem. 2004. PMID: 15287882 Review.
Cited by
-
Neuropathic Pain and Spinal Cord Injury: Management, Phenotypes, and Biomarkers.Drugs. 2023 Jul;83(11):1001-1025. doi: 10.1007/s40265-023-01903-7. Epub 2023 Jun 16. Drugs. 2023. PMID: 37326804 Review.
-
Can neuroimaging studies identify pain endophenotypes in humans?Nat Rev Neurol. 2011 Mar;7(3):173-81. doi: 10.1038/nrneurol.2011.4. Epub 2011 Feb 8. Nat Rev Neurol. 2011. PMID: 21304481 Review.
-
Somatosensory phenotype is associated with thalamic metabolites and pain intensity after spinal cord injury.Pain. 2015 Jan;156(1):166-174. doi: 10.1016/j.pain.0000000000000019. Pain. 2015. PMID: 25599312 Free PMC article.
-
Pain imaging in health and disease--how far have we come?J Clin Invest. 2010 Nov;120(11):3788-97. doi: 10.1172/JCI43498. Epub 2010 Nov 1. J Clin Invest. 2010. PMID: 21041961 Free PMC article. Review.
-
Extracellular N-acetylaspartylglutamate released in the nucleus accumbens modulates the pain sensation: Analysis using a microdialysis/mass spectrometry integrated system.Mol Pain. 2018 Jan-Dec;14:1744806918754934. doi: 10.1177/1744806918754934. Epub 2018 Jan 8. Mol Pain. 2018. PMID: 29310499 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources